Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using 18FDG-PET/CT

[1]  R. Hicks,et al.  Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome , 2011, Diseases of the Colon & Rectum.

[2]  S. Fanti,et al.  Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  I. Lavery,et al.  Downstaging After Chemoradiotherapy for Locally Advanced Rectal Cancer: Is There More (Tumor) Than Meets the Eye? , 2010, Diseases of the colon and rectum.

[4]  Stewart Spies,et al.  Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. , 2009, International journal of radiation oncology, biology, physics.

[5]  Y. Nishiyama,et al.  Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  C. Capirci,et al.  Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. , 2008, International journal of radiation oncology, biology, physics.

[7]  M. Malafa,et al.  PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic Neoplasms , 2008, Annals of Surgical Oncology.

[8]  A. Figer,et al.  An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer , 2008, Annals of Surgical Oncology.

[9]  J. Lindebjerg,et al.  PET/CT and Histopathologic Response to Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer , 2008, Diseases of the colon and rectum.

[10]  H. Nelson,et al.  Is the Increasing Rate of Local Excision for Stage I Rectal Cancer in the United States Justified?: A Nationwide Cohort Study From the National Cancer Database , 2007, Annals of surgery.

[11]  D. Rubello,et al.  Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. , 2006, AJR. American journal of roentgenology.

[12]  P. Morel,et al.  Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent , 2006, World journal of surgical oncology.

[13]  P. Engstrom,et al.  Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience. , 2005, Seminars in oncology.

[14]  M. Tsou,et al.  Interpretation of Magnetic Resonance Imaging for Locally Advanced Rectal Carcinoma After Preoperative Chemoradiation Therapy , 2005, Diseases of the colon and rectum.

[15]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[16]  D. Rubello,et al.  Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[18]  S. Larson,et al.  Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. , 2004, Journal of the American College of Surgeons.

[19]  J. Guillem,et al.  Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer Resection , 2004, Diseases of the colon and rectum.

[20]  M. Desco,et al.  18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. , 2004, International journal of radiation oncology, biology, physics.

[21]  David E. Stein,et al.  Longer Time Interval Between Completion of Neoadjuvant Chemoradiation and Surgical Resection Does Not Improve Downstaging of Rectal Carcinoma , 2003, Diseases of the colon and rectum.

[22]  J. Eary,et al.  [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  K. Ohtomo,et al.  FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer , 2002, Annals of nuclear medicine.

[24]  Elisabeth Kjellén,et al.  FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma , 2002, Head and Neck.

[25]  J. Guillem,et al.  Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. , 2002, Journal of the American College of Surgeons.

[26]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[27]  M. Schwaiger,et al.  Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  A. Padhani,et al.  FDG–PET in the prediction of survival of patients with cancer of the pancreas: a pilot study , 2000, British Journal of Cancer.

[29]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[30]  H. Abdel-Nabi,et al.  Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. , 1998, Radiology.

[31]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[32]  J. Petiot,et al.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.

[33]  G. van Kaick,et al.  Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. , 1992, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].